Gwen E. Weld - Apr 11, 2022 Form 3/A - Amendment Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role: Chief People Officer
Signature: /s/ Matthew B. Murphy, as Attorney-in-Fact
Stock symbol: NAUT
Transactions as of: Apr 11, 2022
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 4/15/2022, 05:07 PM
Date Of Original Report: Apr 13, 2022
Next filing: May 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NAUT	Stock Option (Right to Buy)							Apr 11, 2022	Common Stock	4.54K	$1.14	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan (the "Plan")) through each vesting date, one twenty-fourth (1/24th) of the shares subject to the Option shall vest each month over the twenty-four (24) months following the Vesting Commencement Date (as defined below) on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is September 29, 2020.

Content

Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan (the "Plan")) through each vesting date, one twenty-fourth (1/24th) of the shares subject to the Option shall vest each month over the twenty-four (24) months following the Vesting Commencement Date (as defined below) on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is September 29, 2020.

Remarks:

Form 3 amended to reflect stock option held by reporting person.